Redeye states that Catella’s Q2 report was even stronger than expected. While a turbulent German economy is a threat, Redeye thinks performance in IM will continue to be strong due to reported asset valuations in IM being too low. This is due to a German regulation which will likely prove to be a vital cushion ahead. Redeye raises its valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/